These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9137959)

  • 1. Pharmacology of purine nucleoside analogues.
    Plunkett W; Gandhi V
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S67-74. PubMed ID: 9137959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nucleoside analogues--new drugs for the treatment of lymphatic cancers].
    Itälä M; Remes K
    Duodecim; 2001; 117(2):162-9. PubMed ID: 12092367
    [No Abstract]   [Full Text] [Related]  

  • 3. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders.
    Tallman MS; Hakimian D
    Blood; 1995 Oct; 86(7):2463-74. PubMed ID: 7670093
    [No Abstract]   [Full Text] [Related]  

  • 4. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on purine analogues.
    Cheson BD
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse and beneficial immunological effects of purine nucleoside analogues.
    Dighiero G
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S75-81. PubMed ID: 9137960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
    Saven A
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757
    [No Abstract]   [Full Text] [Related]  

  • 8. Purine analogues in the management of lymphoproliferative diseases.
    Johnson SA
    Clin Oncol (R Coll Radiol); 1996; 8(5):289-96. PubMed ID: 8934048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fludarabine in hematological malignancies.
    Montillo M; Ricci F; Tedeschi A
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1141-61. PubMed ID: 17020450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentostatin in chronic lymphocytic leukemia.
    Sauter C; Lamanna N; Weiss MA
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New prospects in the treatment of indolent lymphomas with purine analogues.
    Cheson BD
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies.
    Plunkett W; Gandhi V; Huang P; Robertson LE; Yang LY; Gregoire V; Estey E; Keating MJ
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):2-12. PubMed ID: 8235690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purine analogs in leukemia.
    Lamanna N; Weiss M
    Adv Pharmacol; 2004; 51():107-25. PubMed ID: 15464907
    [No Abstract]   [Full Text] [Related]  

  • 14. New drugs in the treatment of chronic lymphocytic leukemia.
    Keating MJ; O'Brien S; Robertson L; Plunkett W; Kantarjian H; Koller C
    Leukemia; 1992 Nov; 6 Suppl 4():140-1. PubMed ID: 1359203
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacokinetics of nucleoside analogues: focus on haematological malignancies.
    Johnson SA
    Clin Pharmacokinet; 2000 Jul; 39(1):5-26. PubMed ID: 10926348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new purine analog in the treatment of hematologic malignancy. I. Fludarabine].
    Vásová I; Penka M; Hájek R; Mayer J; Krahulcová E
    Vnitr Lek; 1997 Jan; 43(1):45-50. PubMed ID: 9221567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
    Fabianowska-Majewska K; Wyczechowska D
    Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
    Saven A; Piro LD
    Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with fludarabine in hemato-oncology.
    Keating MJ; O'Brien S; McLaughlin P; Dimopoulos M; Gandhi V; Plunkett W; Lerner S; Kantarjian H; Estey E
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S83-91. PubMed ID: 9137961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine analogs in lymphoproliferative disorders.
    Cheson BD
    Leuk Lymphoma; 1993; 11 Suppl 2():153-9. PubMed ID: 7907252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.